Finance

Lists
600201:SHA
Jinyu Bio-Technology Co Ltd
CNÂ¥12.32
+0.08%
(+0.0100) 1D
Sep 3, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600201...
Open
CNÂ¥12.31
High
CNÂ¥12.45
Low
CNÂ¥12.22
Mkt. cap
13.54B
Avg. vol.
17.11M
Volume
8.59M
Dividend
0.30%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
94.83
52-wk high
CNÂ¥19.00
52-wk low
CNÂ¥7.99
EPS
CNÂ¥0.13
Shares outstanding
1.17B
No. of employees
2K
Open
CNÂ¥12.31
High
CNÂ¥12.45
Low
CNÂ¥12.22
Mkt. cap
13.54B
Avg. vol.
17.11M
Volume
8.59M
Dividend
0.30%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
94.83
52-wk high
CNÂ¥19.00
52-wk low
CNÂ¥7.99
EPS
CNÂ¥0.13
Shares outstanding
1.17B
No. of employees
2K
About Jinyu Bio-Technology Co Ltd
CEO-
Employees1.88K
Founded1992
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
422.84M
354.01M
346.46M
409.98M
Cost of goods sold
180.49M
184.33M
161.17M
200.66M
Cost of revenue
180.49M
184.33M
161.17M
200.66M
Research and development expenses
22.59M
35.07M
20.63M
27.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131.51M
170.00M
92.79M
127.80M
Operating expense
169.59M
249.01M
123.22M
180.94M
Total operating expenses
350.07M
433.34M
284.39M
381.60M
Operating income
72.77M
-79.33M
62.07M
28.38M
Other non operating income
-1.39M
-2.23M
-73.69K
3.09M
EBT including unusual items
105.01M
-74.54M
96.69M
33.94M
EBT excluding unusual items
86.72M
-86.43M
73.03M
42.77M
Income tax expense
4.49M
-10.85M
14.99M
4.21M
Effective tax rate
4.28%
14.56%
15.50%
12.41%
Other operating expenses
3.04M
9.22M
6.04M
11.58M
Net income
100.89M
-61.20M
80.64M
23.46M
Net profit margin
23.86%
-17.29%
23.28%
5.72%
Earnings per share
-
-
-
-
Interest and investment income
14.96M
-
11.08M
11.36M
Interest expense
-
-4.44M
-47.36K
-
Net interest expenses
14.96M
-4.44M
11.03M
11.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
125.12M
-16.41M
125.00M
90.65M
Gain or loss from assets sale
-51.91K
-8.38M
-
-62.76K
AI content may include mistakes. Learn more
Google apps